Nina(Das)ShahMD

PubMed

• B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches.
  Nina Shah, Ajai Chari, Emma C. Scott, Khalid Mezzi, Saad Z. Usmani> ;Leukemia. 2020 Feb 13
• Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.
  Sathish Gopalakrishnan, Anita D'Souza, Emma C. Scott, Raphael Fraser, Omar Davila, Nina Shah, Robert Peter Gale, Rammurti T. Kamble, Miguel Angel Diaz, Hillard M. Laza...> ;Biology of Blood and Marrow Transplantation. 2019 Apr 1
• Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.
  Maymani, H.,Lin, P.,Saliba, R. M.,Popat, U.,Bashir, Q.,Shah, N.,Patel, K.,Parmar, S.,Kebriaei, P.,Hosing, C.,Ciurea, S.,Andersson, B.,Shpall, E.,Champlin, R.,Srour, S....> ;Biol. Blood Marrow Transplant.. 2019 Jan 15
• Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma.
  Stadtmauer, E. A.,Pasquini, M. C.,Blackwell, B.,Hari, P.,Bashey, A.,Devine, S.,Efebera, Y.,Ganguly, S.,Gasparetto, C.,Geller, N.,Horowitz, M. M.,Koreth, J.,Knust, K.,L...> ;J. Clin. Oncol.. 2019 Jan 18
• Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most ...
  Emma C. Scott, Parameswaran Hari, Sathish Kumar, Raphael Fraser, Omar Davila, Nina Shah, Robert Peter Gale, Miguel Angel Diaz, Vaibhav Agrawal, Robert F. Cornell, Sidd...> ;Biology of Blood and Marrow Transplantation. 2018 Dec 1
• Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation.
  Aimaz Afrough, Rima M. Saliba, Amir Hamdi, Medhavi Honhar, Ankur Varma, A. Megan Cornelison, Gabriela Rondon, Simrit Parmar, Nina Shah, Qaiser Bashir, Chitra Hosing, U...> ;Biology of Blood and Marrow Transplantation. 2018 Nov 1
• Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs.
  Gowda, L.,Shah, M.,Badar, I.,Bashir, Q.,Shah, N.,Patel, K.,Kanagal-Shamanna, R.,Mehta, R.,Weber, D. M.,Lee, H. C.,Manasanch, E. E.,Shah, A.,Thomas, S. K.,Parmar, S.,Ni...> ;Bone Marrow Transplant.. 2018 Nov 18
• Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia.
  Lacourt, T. E.,Kavelaars, A.,Ohanian, M.,Shah, N. D.,Shelburne, S. A.,Futreal, A.,Kontoyiannis, D. P.,Heijnen, C. J.> ;Oncotarget. 2018 Aug 23
• High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes.
  Hu, B.,Thall, P.,Milton, D. R.,Sasaki, K.,Bashir, Q.,Shah, N.,Patel, K.,Popat, U.,Hosing, C.,Nieto, Y.,Lin, P.,Delgado, R.,Jorgensen, J.,Manasanch, E.,Weber, D.,Thomas...> ;Leuk. Lymphoma. 2018 Jul 24
• A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center.
  Mohyuddin, G. R.,Faisal, M. S.,Badar, T.,Shah, N.,Bashir, Q.,Patel, K. K.,Hosing, C.,Popat, U. R.,Rondon, G.,Delgado, R.,Shah, J. J.,Weber, D. M.,Thomas, S. K.,Manasan...> ;Leuk. Lymphoma. 2017 Jul 05
• Associations of inflammation with symptom burden in patients with acute myeloid leukemia.
  Lacourt, T. E.,Kavelaars, A.,Galloway-Peña, J. R.,Sahasrabhojane, P. V.,Shah, N. D.,Futreal, A.,Kontoyiannis, D. P.,Shelburne, S. A.,Heijnen, C. J.> ;Psychoneuroendocrinology. 2018 Feb 08
• Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: a NLCS and CIBMTR Analysis.
  Casulo, C.,Friedberg, J. W.,Ahn, K. W.,Flowers, C.,DiGilio, A.,Smith, S. M.,Ahmed, S.,Inwards, D.,Aljurf, M.,Chen, A. I.,Choe, H.,Cohen, J.,Copelan, E.,Farooq, U.,Fens...> ;Biol. Blood Marrow Transplant.. 2017 Dec 16
• Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.
  Shah, N.,Cornelison, A. M.,Saliba, R.,Ahmed, S.,Nieto, Y. L.,Bashir, Q.,Parmar, S.,Hosing, C.,Popat, U.,Shpall, E. J.,Champlin, R. E.,Qazilbash, M.> ;Eur. J. Haematol.. 2017 Sep 13
• Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
  Veltri, L. W.,Milton, D. R.,Delgado, R.,Shah, N.,Patel, K.,Nieto, Y.,Kebriaei, P.,Popat, U. R.,Parmar, S.,Oran, B.,Ciurea, S.,Hosing, C.,Lee, H. C.,Manasanch, E.,Orlow...> ;Cancer. 2017 May 18
• 4 citations
  Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
  Ankur Varma, Laura Biritxinaga, Rima M. Saliba, Maximilian Stich, Sarah Francesca Jauch, Aimaz Afrough, Medhavi Honhar, Uday R. Popat, Mehnaz A. Shafi, Nina Shah, Qais...> ;Biology of Blood and Marrow Transplantation. 2017 Apr 1
• Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma.
  Shah, N.,Li, L.,McCarty, J.,Kaur, I.,Yvon, E.,Shaim, H.,Muftuoglu, M.,Liu, E.,Orlowski, R. Z.,Cooper, L.,Lee, D.,Parmar, S.,Cao, K.,Sobieiski, C.,Saliba, R.,Hosing, C....> ;Br. J. Haematol.. 2017 Mar 16
• Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse ris...
  Thompson, P. A.,Stingo, F.,Keating, M. J.,Wierda, W. G.,O'Brien, S. M.,Estrov, Z.,Ledesma, C.,Rezvani, K.,Qazilbash, M.,Shah, N.,Parmar, S.,Popat, U.,Anderlini, P.,Yag...> ;Br. J. Haematol.. 2017 Mar 16
• Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and ...
  Ge, I.,Saliba, R. M.,Maadani, F.,Popat, U. R.,Qazilbash, M. H.,Ravi Pingali, S.,Shah, N.,Ahmed, S.,Bashir, Q.,Nieto, Y.,Champlin, R. E.,Hosing, C.> ;Transfusion. 2017 Feb 12
• Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL).
  Shah N, Rauenzahn S, Veltri L, Wen S, Craig M, Hamadani M, Kanate AS, Cumpston A> ;Bone Marrow Transplant.. 2016-11-28
• Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.
  Badar T, Srour S, Bashir Q, Shah N, Al-Atrash G, Hosing C, Popat U, Nieto Y, Orlowski RZ, Champlin R, Qazilbash MH> ;Eur. J. Haematol.. 2016-11-09
• Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.
  Gaballa S, Saliba RM, Srour S, Lu G, Brammer JE, Shah N, Bashir Q, Patel K, Bock F, Parmar S, Hosing C, Popat U, Delgado R, Rondon G, Shah JJ, Manasanch EE, Orlowski R...> ;Am. J. Hematol.. 2016-10-01
• Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.
  Nieto, Y.,Valdez, B. C.,Thall, P. F.,Jones, R. B.,Wei, W.,Myers, A.,Hosing, C.,Ahmed, S.,Popat, U.,Shpall, E. J.,Qazilbash, M.,Gulbis, A.,Anderlini, P.,Shah, N.,Bashir...> ;Cancer. 2016 May 21
• Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
  Pinnix, C. C.,Shah, J. J.,Chuang, H.,Costelloe, C. M.,Medeiros, L. J.,Wogan, C. F.,Reed, V.,Smith, G. L.,Milgrom, S.,Patel, K.,Huo, J.,Turturro, F.,Romaguera, J.,Fayad...> ;Clin Lymphoma Myeloma Leuk. 2016 Jan 23
• Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement.
  Cornelison, A. M.,Saliba, R. M.,Afrough, A.,Dinh, Y.,Nieto, Y.,Bashir, Q.,Shah, N.,Parmar, S.,Hosing, C.,Popat, U.,Shpall, E.,Champlin, R.,Qazilbash, M. H.> ;Bone Marrow Transplant.. 2015 Oct 20
• Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.
  Aung, F. M.,Lichtiger, B.,Rondon, G.,Yin, C. C.,Alousi, A.,Ahmed, S.,Andersson, B.,Bashier, Q.,Ciurea, S. O.,Hosing, C.,Jones, R.,Kebriaei, P.,Khouri, I.,Nieto, Y.,Ora...> ;Biol. Blood Marrow Transplant.. 2016 Feb 28
• Join now to see all

Abstracts/Posters

• Germline Variation Predicts Treatment Response in Multiple Myeloma
  Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and _Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and Biology
  Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Cord Blood Regulatory T Cells Prevent Mutiple Myeloma Progression By Suppressing Inflammation
  Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma
  Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)Clinically Relevant Abstract
  Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy
  Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)
  Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnose...
  Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation
  Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• A Phase 1, Open-Label, Multi-Center, Dose Escalation and Dose Expansion Study of NKTR-255 As a Single Agent in Relapsed or Refractory Hematologic Malignancies and in C... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Immunotherapy in Myeloma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Daratumumab (DARA) Plus Lenalidomide Versus Lenalidomide Alone As Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma (NDMM) after Frontline Autolo... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019